Analysts' Opinions Are Mixed on These Healthcare Stocks: Elevance Health (ELV), Intuitive Surgical (ISRG) and Walgreens Boots Alliance (WBA)
Walgreens Boots Alliance (WBA) Gets a Hold From Evercore ISI
TD Cowen Maintains Walgreens Boots Alliance(WBA.US) With Buy Rating, Maintains Target Price $15
Walgreens Boots Alliance (WBA) Gets a Buy From TD Cowen
Walgreens Boots Alliance Is Maintained at Hold by Truist Securities
Truist Financial Initiates Walgreens Boots Alliance(WBA.US) With Hold Rating, Announces Target Price $13
Walgreens Boots Alliance Is Maintained at Sector Perform by RBC Capital
RBC Capital Maintains Walgreens Boots Alliance(WBA.US) With Hold Rating, Raises Target Price to $12
RBC Raises Price Target on Walgreens Boots Alliance to $12 From $9, Keeps Sector Perform Rating
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Quanterix (QTRX) and Walgreens Boots Alliance (WBA)
A Quick Look at Today's Ratings for Walgreens Boots Alliance(WBA.US), With a Forecast Between $7 to $15
Jefferies Adjusts Walgreens Boots Alliance Price Target to $11 From $9
TD Cowen Adjusts Price Target on Walgreens Boots Alliance to $15 From $14
Walgreens Boots Alliance Is Maintained at Underperform by B of A Securities
Walgreens Boots Alliance Price Target Raised to $8.50/Share From $7.50 by B of A Securities
Walgreens Boots Alliance Analyst Ratings
Truist Financial Sticks to Its Hold Rating for Walgreens Boots Alliance (WBA)
BofA Securities Maintains Walgreens Boots Alliance(WBA.US) With Sell Rating, Raises Target Price to $8.5
Deutsche Bank Adjusts Walgreens Boots Alliance Price Target to $11 From $10, Maintains Hold Rating
Challenges in Profitability and Financial Flexibility Lead to Sell Rating on Walgreens Boots Alliance